Response to Han and Liu
J Natl Cancer Inst
.
2025 May 1;117(5):1082-1083.
doi: 10.1093/jnci/djaf026.
Authors
Serigne N Lo
1
2
,
Alexander H R Varey
1
2
3
,
Sydney Ch'ng
1
2
4
,
Richard A Scolyer
1
2
5
6
,
John F Thompson
1
2
4
7
Affiliations
1
Melanoma Institute Australia, The University of Sydney, North Sydney, NSW 2060, Australia.
2
Faculty of Health and Medicine, The University of Sydney, Sydney, NSW 2050, Australia.
3
Department of Plastic Surgery, Westmead Hospital, Sydney, NSW 2145, Australia.
4
Department of Melanoma and Surgical Oncology, Royal Prince Alfred Hospital, Sydney, NSW 2050, Australia.
5
Tissue Pathology and Diagnostic Oncology, Royal Prince Alfred Hospital and NSW Health Pathology, Sydney, NSW 2050, Australia.
6
Charles Perkins Centre, The University of Sydney, Sydney, NSW 2050, Australia.
7
Faculty of Health and Medical Sciences, The University of Western Australia, Perth, WA 6009, Australia.
PMID:
39913373
DOI:
10.1093/jnci/djaf026
No abstract available
Grants and funding
Melanoma Institute Australia
2022/GNT2018514/National Health and Medical Research Council